# Boston Scientific to acquire Cryterion Medical for $202M

Boston Scientific Corporation announced a definitive agreement to acquire Cryterion Medical, a developer of a single-shot cryoablation platform for atrial fibrillation, for $202 million in upfront cash for the approximately 65% stake not already owned.

- Type: Acquisition
- Announced: 2018-07-05
- Value: $202.0M
- Status: announced
- Products: cryoablation platform, balloon catheter, mapping catheter, steerable sheath
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boston Scientific](https://endata.com/companies/15966.md) (acquirer)
- [Cryterion Medical](https://endata.com/companies/32951.md) (target)

## Sources

- [cardiacrhythmnews.com](https://cardiacrhythmnews.com/boston-scientific-to-acquire-cryterion-medical/), 2018-07-05: "Initial clinical study results demonstrate that our system has a promising safety profile as well as acute efficacy."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.